ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Eramol Therapeutics Limited

Eramol Therapeutics Limited is an active company incorporated on 29 December 2021 with the registered office located in Sevenoaks, Kent. Eramol Therapeutics Limited was registered 3 years ago.
Status
Active
Active since incorporation
Company No
13819181
Private limited company
Age
3 years
Incorporated 29 December 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 28 December 2024 (11 months ago)
Next confirmation dated 28 December 2025
Due by 11 January 2026 (1 month remaining)
Last change occurred 11 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (9 months remaining)
Address
Unit 9 North Downs Business Park
Limepit Lane
Sevenoaks
TN13 2TL
England
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
2
Shareholders
2
Controllers (PSC)
2
PSC • Director • British • Lives in England • Born in Dec 1980 • Pharmacist
Director • Pharmacist • British • Lives in England • Born in Dec 1980
Mr Ka Yan Che
PSC • British • Lives in England • Born in Dec 1980
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Eramol (UK) Ltd
Ka Yan Che and Peter Mollison are mutual people.
Active
Eramol Group Holdings Ltd
Ka Yan Che and Peter Mollison are mutual people.
Active
Curavida Pharma Limited
Ka Yan Che and Peter Mollison are mutual people.
Active
Cadsin Limited
Ka Yan Che and Peter Mollison are mutual people.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£6.59K
Decreased by £5.46K (-45%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£253.87K
Increased by £49.9K (+24%)
Total Liabilities
-£51.86K
Decreased by £153.47K (-75%)
Net Assets
£202K
Increased by £203.37K (-14877%)
Debt Ratio (%)
20%
Decreased by 80.24% (-80%)
Latest Activity
Mr Peter Mollison (PSC) Details Changed
1 Month Ago on 16 Oct 2025
Amended Full Accounts Submitted
2 Months Ago on 4 Oct 2025
Full Accounts Submitted
2 Months Ago on 23 Sep 2025
Mr Peter Mollison Details Changed
3 Months Ago on 4 Sep 2025
Confirmation Submitted
11 Months Ago on 31 Dec 2024
Full Accounts Submitted
1 Year 4 Months Ago on 9 Aug 2024
Eramol Group Holdings Limited (PSC) Resigned
1 Year 9 Months Ago on 28 Feb 2024
Peter Mollison (PSC) Appointed
1 Year 9 Months Ago on 28 Feb 2024
Ka Yan Che (PSC) Appointed
1 Year 9 Months Ago on 28 Feb 2024
Confirmation Submitted
1 Year 11 Months Ago on 28 Dec 2023
Get Credit Report
Discover Eramol Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Change of details for Mr Peter Mollison as a person with significant control on 16 October 2025
Submitted on 16 Oct 2025
Director's details changed for Mr Peter Mollison on 4 September 2025
Submitted on 9 Oct 2025
Amended total exemption full accounts made up to 31 December 2023
Submitted on 4 Oct 2025
Total exemption full accounts made up to 31 December 2024
Submitted on 23 Sep 2025
Confirmation statement made on 28 December 2024 with updates
Submitted on 31 Dec 2024
Total exemption full accounts made up to 31 December 2023
Submitted on 9 Aug 2024
Sub-division of shares on 22 February 2024
Submitted on 4 Mar 2024
Notification of Ka Yan Che as a person with significant control on 28 February 2024
Submitted on 28 Feb 2024
Notification of Peter Mollison as a person with significant control on 28 February 2024
Submitted on 28 Feb 2024
Cessation of Eramol Group Holdings Limited as a person with significant control on 28 February 2024
Submitted on 28 Feb 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year